ID
35716
Description
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus; ODM derived from: https://clinicaltrials.gov/show/NCT02229383
Link
https://clinicaltrials.gov/show/NCT02229383
Keywords
Versions (1)
- 3/17/19 3/17/19 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
March 17, 2019
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Diabetes Mellitus NCT02229383
Eligibility Diabetes Mellitus NCT02229383
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Serum calcitonin measurement
Data type
boolean
Alias
- UMLS CUI [1]
- C0863135
Description
Pancreatitis | Pancreatitis, Chronic | Triglycerides measurement
Data type
boolean
Alias
- UMLS CUI [1]
- C0030305
- UMLS CUI [2]
- C0149521
- UMLS CUI [3]
- C0202236
Description
Hepatitis B Seropositive | Hepatitis C Seropositive
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0019163
- UMLS CUI [1,2]
- C0521143
- UMLS CUI [2,1]
- C0019196
- UMLS CUI [2,2]
- C0521143
Similar models
Eligibility Diabetes Mellitus NCT02229383
- StudyEvent: Eligibility
C0178602 (UMLS CUI [1,2])
C0456683 (UMLS CUI [1,3])
C0009429 (UMLS CUI [2])
C0012159 (UMLS CUI [3])
C0015259 (UMLS CUI [4])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0456683 (UMLS CUI [1,4])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0456683 (UMLS CUI [1,4])
C0038766 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
C0149521 (UMLS CUI [2])
C0202236 (UMLS CUI [3])
C0521143 (UMLS CUI [1,2])
C0019196 (UMLS CUI [2,1])
C0521143 (UMLS CUI [2,2])